CULVERWELL ANTHONY JAMES purchased 31545.7% of their position (100K shares) of QUOIN PHARMACEUTICALS, LTD. on the open market
Open‑market purchase worth $45.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/27/2024ACC: 0001104659-24-132185
Director
Since Feb 2026
+300K
Net shares
Net buyer
$45.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
300K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+100K
Price / share
$0.45
Trade value
$45K
% of position
31545.7%
12/23/2024
317.00→100.32K
Total
Net shares
+100K
Net value
$45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/23/2024 | P · Purchase | +100K | $0.45 | $45K | 31545.7% | 317.00 | 100.32K |
| Total | +100K | $45K | ||||||
Derivative Transactions2
Series F Warrants (right to buy)
Direct
Converts to
ADS
100K shares
Shares
+100K
Strike price
0.45
Held after
100K
Exercisable
—
12/23/2024
Series G Warrants (right to buy)
Direct
Converts to
ADS
100K shares
Shares
+100K
Strike price
0.45
Held after
100K
Exercisable
—
12/23/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series F Warrants (right to buy) Direct | ADS100K shares | 12/23/2024 | P · Purchase | +100K | 0.45 | — | 100K |
| Series G Warrants (right to buy) Direct | ADS100K shares | 12/23/2024 | P · Purchase | +100K | 0.45 | — | 100K |